NVO Jul 2024 129.000 call
- Yahoo Finance Video
Biden, Sanders call for obesity drug makers to cut prices
President Biden and Sen. Bernie Sanders (D-Vt.) are calling for price cuts on popular GLP-1 weight-loss drugs. Pharmaceutical stocks Novo Nordisk (NVO) — who makes Ozempic and Wegovy — and Eli Lilly (LLY) — who makes Mounjaro and Zepbound — tilt lower on the news. Yahoo Finance Health Reporter Anjalee Khemlani details the political discourse around these obesity treatments, citing President Biden and Senator Sanders' op-ed published in USA Today. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Luke Carberry Mogan.
- Bloomberg
Novo, Lilly Fall After Biden Calls for Cheaper Obesity Drugs
(Bloomberg) -- Novo Nordisk A/S and Eli Lilly & Co. shares fell Tuesday after US President Joe Biden continued his push for cheaper medicines by demanding price cuts on their blockbuster weight-loss and diabetes drugs. Most Read from BloombergDemocrats Weigh Mid-July Vote to Formally Tap Biden as NomineeUS Allies Allege China Is Developing Attack Drones for RussiaChina Can End Russia’s War in Ukraine With One Phone Call, Finland SaysS&P 500 Closes Above 5,500 in Record-Breaking Run: Markets Wrap
- Investor's Business Daily
Novo, Lilly Fall After Biden Slams Duo For 'Unconscionably High' Drug Prices
Novo Nordisk stock fell Tuesday after Joe Biden and Bernie Sanders slammed the drugmaker and Eli Lilly for high prices of weight-loss drugs.
